Historique de carrière de Masashi Suganuma
Anciens postes connus de Masashi Suganuma
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CANBAS CO., LTD. | Directeur des opérations | 18/01/2000 | 31/03/2010 |
| Fondateur | 18/01/2000 | 31/03/2010 | |
Luca Science, Inc.
 Luca Science, Inc. BiotechnologyHealth Technology Luca Science, Inc. is a Japanese preclinical stage biopharmaceutical company that specializes in mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tissues and organs. Luca Science is based in Chuo-ku, JP, and was founded in December 2018 by Masashi Suganuma. The company uses its platform technology to manufacture, store, and deliver innovative mitochondrial drugs to research and develop therapeutics for unmet medical needs in a wide range of diseases for which there have been no effective treatments. The CEO is Rick C. Tsai. | Fondateur | - | - |
| Corporate Officer/Principal | - | - |
Statistiques
Internationale
| Japon | 3 |
Opérationnelle
| Founder | 2 |
| Chief Operating Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CANBAS CO., LTD. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Luca Science, Inc.
Luca Science, Inc. BiotechnologyHealth Technology Luca Science, Inc. is a Japanese preclinical stage biopharmaceutical company that specializes in mitochondrial therapy to restore cellular bioenergetics in dysfunctional or damaged tissues and organs. Luca Science is based in Chuo-ku, JP, and was founded in December 2018 by Masashi Suganuma. The company uses its platform technology to manufacture, store, and deliver innovative mitochondrial drugs to research and develop therapeutics for unmet medical needs in a wide range of diseases for which there have been no effective treatments. The CEO is Rick C. Tsai. | Health Technology |
- Bourse
- Insiders
- Masashi Suganuma
- Expérience
